A.R.T. Advisors’s Lexicon Pharmaceuticals LXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-20,677
| Closed | -$41K | – | 185 |
|
|
2020
Q2 | $41K | Buy |
+20,677
| New | +$41K | 0.06% | 233 |
|
|
2019
Q2 | – | Sell |
-48,152
| Closed | -$268K | – | 1513 |
|
|
2019
Q1 | $268K | Buy |
+48,152
| New | +$268K | 0.02% | 980 |
|
|
2018
Q4 | – | Sell |
-28,200
| Closed | -$300K | – | 1518 |
|
|
2018
Q3 | $300K | Sell |
28,200
-14,600
| -34% | -$155K | 0.01% | 1037 |
|
|
2018
Q2 | $513K | Sell |
42,800
-11,466
| -21% | -$137K | 0.02% | 910 |
|
|
2018
Q1 | $465K | Buy |
54,266
+22,533
| +71% | +$193K | 0.02% | 987 |
|
|
2017
Q4 | $313K | Buy |
+31,733
| New | +$313K | 0.01% | 1046 |
|
|
2017
Q3 | – | Sell |
-34,400
| Closed | -$565K | – | 1521 |
|
|
2017
Q2 | $565K | Buy |
34,400
+9,700
| +39% | +$159K | 0.03% | 749 |
|
|
2017
Q1 | $354K | Sell |
24,700
-9,700
| -28% | -$139K | 0.02% | 936 |
|
|
2016
Q4 | $475K | Buy |
+34,400
| New | +$475K | 0.03% | 772 |
|
|
2016
Q2 | – | Sell |
-14,574
| Closed | -$174K | – | 1511 |
|
|
2016
Q1 | $174K | Buy |
+14,574
| New | +$174K | 0.01% | 1200 |
|
|
2014
Q2 | – | Sell |
-18,519
| Closed | -$224K | – | 1432 |
|
|
2014
Q1 | $224K | Sell |
18,519
-57
| -0.3% | -$689 | 0.01% | 1115 |
|
|
2013
Q4 | $234K | Buy |
18,576
+2,367
| +15% | +$29.8K | 0.01% | 1059 |
|
|
2013
Q3 | $270K | Hold |
16,209
| – | – | 0.01% | 1018 |
|
|
2013
Q2 | $246K | Buy |
+16,209
| New | +$246K | 0.01% | 1104 |
|